Phosphoric acid, butyl ester

Genetic toxicity: in vivo

Administrative data

Endpoint:

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

weight of evidence

Study period:

Mar - Aug 1999

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Guideline conform GLP study.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1999

Report date:

1999

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)

Deviations:

no

GLP compliance:

yes

Type of assay:

micronucleus assay

Test material

Test material information

Constituent 1

Reference substance name:

Dibutyl hydrogen phosphate

EC Number:

203-509-8

EC Name:

Dibutyl hydrogen phosphate

Cas Number:

107-66-4

Molecular formula:

C8H19O4P

IUPAC Name:

Phosphoric acid dibutyl ester

Test material form:

other: liquid

Test animals

Species:

mouse

Strain:

NMRI

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: harlan Winkelmann GmbH, Borchen, Germany
- Age at study initiation: 7 weeks
- Weight at study initiation: males - 33.3 g, females - 27.5 g
- Assigned to test groups randomly: yes
- Housing: in makrolon cages type 3 (5 per cage) on softwood granulate
- Diet (e.g. ad libitum): rat/mice diet ssniff R/M-H (V 1534), ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 50 +/- 20%
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 18.5. To: 22.6.1999

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

- Vehicle(s)/solvent(s) used: deionized water
- Concentration of test material in vehicle: 1%, 3% or 10%
- Amount of vehicle (if gavage or dermal): 10 mL/kg bw

Details on exposure:

PREPARATION OF DOSING SOLUTIONS:
On days of administration the test substance was emulsified in deionized water at the appropriate concentrations. A magentic stirrer was used to keep the preparations homogeneous until dosing had been completed.

Duration of treatment / exposure:

twice at an interval of 24 h

Frequency of treatment:

twice

Post exposure period:

24 h after dosing

Doses / concentrations

Doses / concentrations 1

Remarks:

Doses / Concentrations:
100 mg/kg bw
Basis:
actual ingested

Doses / concentrations 2

Remarks:

Doses / Concentrations:
300 mg/kg bw
Basis:
actual ingested

Doses / concentrations 3

Remarks:

Doses / Concentrations:
1000 mg/kg bw
Basis:
actual ingested

No. of animals per sex per dose:

5

Control animals:

yes, concurrent vehicle

Positive control(s):

50 mg/kg bw Endoxan containing Cyclophosphamide

Examinations

Tissues and cell types examined:

erythrocytes from femor bone marrow

Details of tissue and slide preparation:

CRITERIA FOR DOSE SELECTION:
In a preliminary dose range findingstudy, oral administration of 1200 kg/kg bw and higher doses caused strong clinical signs of toxicity and resulted in mortality in male and female mice. Oral administration of 1000 mg/kg bw resulted in mortality in one male mouse.

TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
The test substance was administered twice at an interval of 24 h orally by gavage to the test animals at doses of 100, 300 and 1000 mg/kg bw. The vehicle and positive control was administered in the same way.
Following dosing, the animals were examined regularly for mortality and clinical signs of toxicity.

DETAILS OF SLIDE PREPARATION:
For each animal, about 3 mL fetal bovine serum was poured into a centrifuge tube. Both femora were removed and the bones freed of muscle tissue. The proximal ends of the femora were opened and the bone marrow flushed into the centrifuge tube. A suspension was formed. The mixture was then centrifuged for 5 min. at approx. 1200 rpm, after which almost all the supernatant was discarded. One drop of the thoroughly mixed sediment was smeared onto a cleaned slide, identified by project code and animal number and air-dried for about 12 h. The cells were stained with Giemsa.

Evaluation criteria:

2000 polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded, not the number of individual micronuclei. In addition, the ratio of polychromatic erythrocytes to 200 total erythrcytes was determined. Main parameter for the statistical analysis, i.e. validity assessment of the study and mutagenicity of the test substance was the proportion of polychromatic erythrocytey with micronuclei out of the 2000 counted erythrocytes. All bone marrow smears for evaluation were coded to ensure that the group from which they were taken remained unknown to the investigator.

Criteria for a positive response:
Both biological and statstical significances were considered together for evaluation puproses.
A substance is considered as positive if there is a significant dose-related increase in the number of micronucleated polychromatic erythrocytes compared with the concurrent negative control group. A test substance producing no significant dose-related increase in the number of micronucleated polychromatic erythrocytes is considered non-mutagenic in this system.

Statistics:

A one-sided Wilcoxon-Test was evaluated to check the validity of the study. The study was considered as valid in case the proportion of polychromatic reythrocytes with micronclei in the positive control was significantly higher than in the negative control (p = 0.05).
If the validity of the study had been shown the following sequential test procedure for the examination of the mutagenicity was applied: Based on a monotone-dose-relationshi one-sided Wilcoxon tests were performed starting with the highest dose group. These tests were performed with a multiple level of significance of 5%.

Results and discussion

Test results

Test results 1

Sex:

female

Genotoxicity:

negative

Toxicity:

yes

Remarks:

at 1000 mg/kg bw

Vehicle controls validity:

valid

Positive controls validity:

valid

Test results 2

Sex:

male

Genotoxicity:

negative

Toxicity:

no effects

Vehicle controls validity:

valid

Positive controls validity:

valid

Additional information on results:

Oral administration of 1000 mg/kg bw resulted in the death of 2 female out of 5 animals treated. These animals wer replaced and survived after treatment. The following clinical sign was observed: motor activity decreased.
The dissection of the 2 female animlas which died within 24 h after the first application revealed the following macroscopic finding: intestinal tract filled with orange colored spume. The dissection of all other animals revealed no test substance related macroscopic findings.

The inicidence of micronucleated polychromatic erythrocytes in the dose groups of Phosphoric acid, butyl ester was within the normal range of the negative control group. No statisitcally significant increase of micronucleated polychromatic erythrocytes was observed. The ratio of polychromatic erythrocytes to total erythrocytes remained essentailly unaffected by the test compound and was not less than 20% of the control values.

Cyclophosphamide induced a marked and statistically significant increae in the number of polychromatic erythrocytes with micronuclei, thus indicating the sensitivty of the test system.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information): negative
The results lead to the conclusion that Phosphoric acid, butyl ester did not cause a substantial increase of microncleated polychromatic erythrocytes and is not mutagenic in the micronucleus test under the conditions described.

Executive summary:

The test substance was administered twice at an interval of 24 h orally by gavage to the test animals at doses of 100, 300 and 1000 mg/kg bw. The vehicle and positive control was administered in the same way. Following dosing, the animals were examined regularly for mortality and clinical signs of toxicity.

The number of polychromatic erythrocytes was examined.

Oral administration of 1000 mg/kg bw resulted in the death of 2 female out of 5 animals treated. These animals wer replaced and survived after treatment. The following clinical sign was observed: motor activity decreased. The dissection of the 2 female animlas which died within 24 h after the first application revealed the following macroscopic finding: intestinal tract filled with orange colored spume. The dissection of all other animals revealed no test substance related macroscopic findings. The inicidence of micronucleated polychromatic erythrocytes in the dose groups of Phosphoric acid, butyl ester was within the normal range of the negative control group. No statisitcally significant increase of micronucleated polychromatic erythrocytes was observed. The ratio of polychromatic erythrocytes to total erythrocytes remained essentailly unaffected by the test compound and was not less than 20% of the control values. Cyclophosphamide induced a marked and statistically significant increae in the number of polychromatic erythrocytes with micronuclei, thus indicating the sensitivty of the test system.